Moreover, the co-incubation of U46619 and ifetroban led to a similar reduction in platelet-tumor cell adhesion, confirming that ifetroban can inhibit TPr signaling and prevent platelet-tumor cell adhesion even in the presence of activating signals. This evidence concerns the gene TPR and neoplasm.